Care-seeking delay of patients with heart failure in China: a mixed-method study

Mengqi Xu1,2, Tiantian Ruan3, Xiaoli Huang4

  • 1Department of Nursing, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ESC Heart Failure
|April 3, 2024
PubMed

Insights

Care-seeking delay in heart failure (HF) patients in China averaged 7.5 days, influenced by symptom burden, depression, and pandemic-related factors. Addressing these can improve timely treatment for HF patients.

Area of Science:

  • Cardiology and Public Health
  • Health Services Research

Background:

  • Heart failure (HF) poses a significant health burden in China.
  • Timely care-seeking is crucial for effective heart failure management.
  • Understanding care-seeking delays is essential for improving patient outcomes.

Purpose of the Study:

  • To investigate the duration of care-seeking delay in Chinese heart failure patients.
  • To identify factors influencing care-seeking delay among heart failure patients in China.

Main Methods:

  • A convergent mixed-method design integrating cross-sectional and qualitative studies.
  • Recruited 258 heart failure patients and healthcare professionals from general and community hospitals.
  • Followed STROBE and COREQ guidelines for study conduct and reporting.

Main Results:

  • The median care-seeking delay for heart failure patients was 7.5 days.
  • Prolonged delay was associated with higher oedema symptom burden, higher depression scores, and lower dyspnoea symptom burden.
  • Factors like the COVID-19 pandemic, medical system support, and caregiver abilities also influenced delay duration.

Conclusions:

  • Care-seeking delay among heart failure patients in China requires significant attention.
  • Symptom burden (dyspnoea, oedema), depression, pandemic context, medical support, and caregiver skills are key influencing factors.
  • Interventions targeting these factors may reduce heart failure care-seeking delays.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
323
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
321